Physician profile
Billy Noel
NPI 1790716314
$1,257.32
in general payments reported to CMS, 2019-2025
7 companies · $659 in 2025
The $659 reported for 2025 was more than what 85% of General Practice (Registered Nurse) providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.19 · 2022: $141 · 2023: $273 · 2024: $174 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $739.29 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $254.68 | 2025 | Nuzyra, Xhance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $184.59 | 2025 | Caplyta |
| Medtronic, INC. | $36.22 | 2025 | Minimed 780g |
| Axsome Therapeutics, INC. | $17.88 | 2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $13.47 | 2023 | Seglentis |
| Pfizer INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.